Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Aoki

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Clinical Lymphoma, Myeloma & Leukemia|April 21, 2018
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Taiki Andou, Masatsugu Tanaka, et al.
Bone Marrow Transplantation|August 16, 2018
Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decadesMasamitsu Yanada, Masayoshi Masuko, Jinichi Mori, et al.
Cytotherapy|April 16, 2024
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantationTakayoshi Tachibana, Takuya Miyazaki, Ayako Matsumura, et al.
Leukemia Research|January 13, 2016
Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective studyHidehiro Itonaga, Masako Iwanaga, Kazunari Aoki, et al.
Leukemia & Lymphoma|August 5, 2021
Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromesMasamitsu Yanada, Shohei Mizuno, Satoshi Yamasaki, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
The Lancet. Haematology|November 26, 2021
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trialKazunori Murai, Hiroshi Ureshino, Takashi Kumagai, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Clinical Lymphoma, Myeloma & Leukemia|April 21, 2018
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Taiki Andou, Masatsugu Tanaka, et al.
Bone Marrow Transplantation|August 16, 2018
Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decadesMasamitsu Yanada, Masayoshi Masuko, Jinichi Mori, et al.
Cytotherapy|April 16, 2024
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantationTakayoshi Tachibana, Takuya Miyazaki, Ayako Matsumura, et al.
Leukemia Research|January 13, 2016
Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective studyHidehiro Itonaga, Masako Iwanaga, Kazunari Aoki, et al.
Leukemia & Lymphoma|August 5, 2021
Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromesMasamitsu Yanada, Shohei Mizuno, Satoshi Yamasaki, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
The Lancet. Haematology|November 26, 2021
Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trialKazunori Murai, Hiroshi Ureshino, Takashi Kumagai, et al.
Pageof 15